Christoph K. Winkler
University of Graz
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christoph K. Winkler.
Journal of Biotechnology | 2012
Christoph K. Winkler; Gábor Tasnádi; Dorina Clay; Mélanie Hall; Kurt Faber
Highlights ► Activated C 000000000000 000000000000 000000000000 111111111111 000000000000 111111111111 000000000000 000000000000 000000000000 C bonds bearing electron-withdrawing groups are efficiently reduced by flavoproteins from the OYE family. ► The application of ene-reductases for the pharma- and perfumery industry has been demonstrated. ► Access to both stereoisomeric products is feasible by choice of stereo-complementary enzymes or via proper substrate engineering.
Molecules | 2017
Mathias Pickl; Christoph K. Winkler; Silvia M. Glueck; Marco W. Fraaije; Kurt Faber
The oxidation of alcohols to the corresponding carbonyl or carboxyl compounds represents a convenient strategy for the selective introduction of electrophilic carbon centres into carbohydrate-based starting materials. The O2-dependent oxidation of prim-alcohols by flavin-containing alcohol oxidases often yields mixtures of aldehyde and carboxylic acid, which is due to “over-oxidation” of the aldehyde hydrate intermediate. In order to directly convert alcohols into carboxylic acids, rational engineering of 5-(hydroxymethyl)furfural oxidase was performed. In an attempt to improve the binding of the aldehyde hydrate in the active site to boost aldehyde-oxidase activity, two active-site residues were exchanged for hydrogen-bond-donating and -accepting amino acids. Enhanced over-oxidation was demonstrated and Michaelis–Menten kinetics were performed to corroborate these findings.
Organic Letters | 2011
Yanto Yanto; Christoph K. Winkler; Stephanie Lohr; Mélanie Hall; Kurt Faber; Andreas S. Bommarius
Asymmetric trans-bioreduction of activated alkenes by KYE1 from Kluyveromyces lactis and Yers-ER from Yersinia bercovieri, two ene-reductases from the Old Yellow Enzyme family, showed a broad substrate spectrum with a moderate to excellent degree of stereoselectivity. Both substrate- and enzyme-based stereocontrols were observed to furnish opposite stereoisomeric products. The effects of organic solvents on enzyme activity and stereoselectivity were outlined in this study, where two-phase systems hexane and toluene are shown to sustain bioreduction efficiency even at high organic solvent content.
Nature Communications | 2014
Georg Steinkellner; Christian C. Gruber; Tea Pavkov-Keller; Alexandra Binter; Kerstin Steiner; Christoph K. Winkler; Andrzej Lyskowski; O. Schwamberger; Monika Oberer; Helmut Schwab; Kurt Faber; Peter Macheroux; Karl Gruber
The exploitation of catalytic promiscuity and the application of de novo design have recently opened the access to novel, non-natural enzymatic activities. Here we describe a structural bioinformatic method for predicting catalytic activities of enzymes based on three-dimensional constellations of functional groups in active sites (‘catalophores’). As a proof-of-concept we identify two enzymes with predicted promiscuous ene-reductase activity (reduction of activated C–C double bonds) and compare them with known ene-reductases, that is, members of the Old Yellow Enzyme family. Despite completely different amino acid sequences, overall structures and protein folds, high-resolution crystal structures reveal equivalent binding modes of typical Old Yellow Enzyme substrates and ligands. Biochemical and biocatalytic data show that the two enzymes indeed possess ene-reductase activity and reveal an inverted stereopreference compared with Old Yellow Enzymes for some substrates. This method could thus be a tool for the identification of viable starting points for the development and engineering of novel biocatalysts.
Journal of Organic Chemistry | 2013
Christoph K. Winkler; Dorina Clay; Simon B. Davies; Pat O’Neill; Paul Oliver Mcdaid; Sébastien Debarge; Jeremy Steflik; Mike Karmilowicz; John Wing Wong; Kurt Faber
The asymmetric bioreduction of a library of β-cyanoacrylate esters using ene-reductases was studied with the aim to provide a biocatalytic route to precursors for GABA analogues, such as pregabalin. The stereochemical outcome could be controlled by substrate-engineering through size-variation of the ester moiety and by employing stereochemically pure (E)- or (Z)-isomers, which allowed to access both enantiomers of each product in up to quantitative conversion in enantiomerically pure form. In addition, stereoselectivities and conversions could be improved by mutant variants of OPR1, and the utility of the system was demonstrated by preparative-scale applications.
Biotechnology and Bioengineering | 2013
Christoph K. Winkler; Dorina Clay; Esta van Heerden; Kurt Faber
Eleven flavoproteins from the old yellow enzyme family were found to catalyze the disproportionation (“dismutation”) of conjugated enones. Incomplete conversions, which were attributed to enzyme inhibition by the co‐product phenol could be circumvented via in situ co‐product removal by scavenging the phenol using the polymeric adsorbent MP‐carbonate. The optimized system allowed to reduce an alkene activated by ester groups in a “coupled‐substrate” approach via nicotinamide‐free hydrogen transfer with >90% conversion and complete stereoselectivity. Biotechnol. Bioeng. 2013;110: 3085–3092.
Catalysis Science & Technology | 2012
Gábor Tasnádi; Christoph K. Winkler; Dorina Clay; Mélanie Hall; Kurt Faber
The enzymatic bioreduction of β-halo-α,β-unsaturated carboxylic esters proceeded via sequential enzymatic CC reduction—β-elimination to afford saturated carboxylic esters. This novel biodegradation pathway combines the reductive activity of ene-reductases with the spontaneous β-elimination of hydrohalous acid from the unstable (saturated) intermediates. Both enantiomers of methyl 2-chloro-, 2-bromo- and 2-iodopropionate were obtained in good to excellent enantiopurity via enzyme-based stereocontrol using various members of the ‘Old Yellow Enzyme’ family of flavoproteins. Overall, this pathway resembles a reductive dehalogenation of β-halogenated acrylic esters.
Advanced Synthesis & Catalysis | 2014
Christoph K. Winkler; Dorina Clay; Nikolaus G. Turrini; Horst Lechner; Wolfgang Kroutil; Simon Davies; Sebastien Debarge; Pat O'Neill; Jeremy Steflik; Mike Karmilowicz; John Wing Wong; Kurt Faber
Asymmetric bioreduction of an (E)-β-cyano-2,4-dienoic acid derivative by ene-reductases allowed a shortened access to a precursor of pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid] possessing the desired configuration in up to 94% conversion and >99% ee. Deuterium labelling studies showed that the nitrile moiety was the preferred activating/anchor group in the active site of the enzyme over the carboxylic acid or the corresponding methyl ester.
Monatshefte Fur Chemie | 2016
Margit Winkler; Christoph K. Winkler
The first carboxylate reductase from Trametes versicolor was identified, cloned, and expressed in Escherichia coli. The enzyme reduces aromatic acids such as benzoic acid and derivatives, cinnamic acid, and 3-phenylpropanoic acid, but also aliphatic acids such as octanoic acid are reduced.Graphical abstract
Chemistry: A European Journal | 2014
Christoph K. Winkler; Dorina Clay; Marcello Entner; Markus Plank; Kurt Faber
To develop a nicotinamide-independent single flavoenzyme system for the asymmetric bioreduction of C=C bonds, four types of hydrogen donor, encompassing more than 50 candidates, were investigated. Six highly potent, cheap, and commercially available co-substrates were identified that (under the optimized conditions) resulted in conversions and enantioselectivities comparable with, or even superior to, those obtained with traditional two-enzyme nicotinamide adenine dinucleotide phosphate (NAD(P)H)-recycling systems.